ResearcherChugai Pharmaceutical Co., Ltd. (Japan)Active in the last 2 years
Hiroyuki Tsunoda
Matched on ORCID iD 0009-0005-5016-4366; OpenAlex author ID A5009149364. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers
Papers 3
- MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2026.218348↗
- Corrigendum to "MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma" [Cancer Lett. 645, (2026), 21834… Co-author DOI 10.1016/j.canlet.2026.218794↗
- Fibroblast inhibition by tocilizumab enabled gemcitabine/nab-paclitaxel rechallenge for pancreatic cancer. Last author DOI 10.1111/cas.15929↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kazunori Aoki · 3 shared papers, 2023–2026 · strength 0.55
- Paper MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2026.218348↗
- Paper Corrigendum to "MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocar… DOI 10.1016/j.canlet.2026.218794↗
- Paper Fibroblast inhibition by tocilizumab enabled gemcitabine/nab-paclitaxel rechallenge for pancreatic cancer. DOI 10.1111/cas.15929↗
- Atsushi Ochiai · 3 shared papers, 2023–2026 · strength 0.55
- Paper MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2026.218348↗
- Paper Corrigendum to "MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocar… DOI 10.1016/j.canlet.2026.218794↗
- Paper Fibroblast inhibition by tocilizumab enabled gemcitabine/nab-paclitaxel rechallenge for pancreatic cancer. DOI 10.1111/cas.15929↗
- Keisuke Sekine · 2 shared papers, 2026 · strength 0.40
- Paper MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2026.218348↗
- Paper Corrigendum to "MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocar… DOI 10.1016/j.canlet.2026.218794↗
- Satoshi Nara · 2 shared papers, 2026 · strength 0.40
- Paper MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2026.218348↗
- Paper Corrigendum to "MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocar… DOI 10.1016/j.canlet.2026.218794↗
- Hironori Fukuda · 2 shared papers, 2026 · strength 0.40
- Paper MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2026.218348↗
- Paper Corrigendum to "MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocar… DOI 10.1016/j.canlet.2026.218794↗
- Nobuyoshi Hiraoka · 2 shared papers, 2026 · strength 0.40
- Paper MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2026.218348↗
- Paper Corrigendum to "MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocar… DOI 10.1016/j.canlet.2026.218794↗
- Minoru Esaki · 2 shared papers, 2026 · strength 0.40
- Paper MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2026.218348↗
- Paper Corrigendum to "MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocar… DOI 10.1016/j.canlet.2026.218794↗
- Mami Takahashi · 1 shared paper, 2026 · strength 0.20
- Shuichi Mitsunaga · 1 shared paper, 2023 · strength 0.15
- Kazuo Watanabe · 1 shared paper, 2023 · strength 0.15
- Mitsuhito Sasaki · 1 shared paper, 2023 · strength 0.15
- Masafumi Ikeda · 1 shared paper, 2023 · strength 0.15
- Toshihiro Yamaguchi · 1 shared paper, 2023 · strength 0.15
- Hiroshi Imaoka · 1 shared paper, 2023 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.